Sam P. Nayler
Brisbane, QLD 4006, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Recent Advances in Therapy for the Neurodegenerative Disorder Ataxia-Telangiectasia.
Journal: International journal of molecular sciences
Published: July 20, 2026
Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia: treating mitochondrial dysfunction with anaplerosis.
Journal: EBioMedicine
Published: January 17, 2025
A Survey of the Metabolic Landscape of the Developing Cerebellum at Single-Cell Resolution.
Journal: Cerebellum (London, England)
Published: May 09, 2022
Lentiviral Reprogramming of A-T Patient Fibroblasts to Induced Pluripotent Stem Cells.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 07, 2017
Human iPSC-Derived Cerebellar Neurons from a Patient with Ataxia-Telangiectasia Reveal Disrupted Gene Regulatory Networks.
Journal: Frontiers in cellular neuroscience
Published: March 23, 2017
A new model to study neurodegeneration in ataxia oculomotor apraxia type 2.
Journal: Human molecular genetics
Published: February 13, 2015
Induced pluripotent stem cells from ataxia-telangiectasia recapitulate the cellular phenotype.
Journal: Stem cells translational medicine
Published: December 01, 2012
The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing.
Journal: Molecular psychiatry
Published: September 14, 2012
Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.
Journal: Stem cells (Dayton, Ohio)
Published: July 25, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026